Prothena Corporation plc
PRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $135 | $91 | $54 | $201 |
| % Growth | 47.9% | 69.5% | -73.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $135 | $91 | $54 | $201 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $223 | $221 | $136 | $82 |
| G&A Expenses | $67 | $62 | $50 | $46 |
| SG&A Expenses | $67 | $62 | $50 | $46 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $290 | $282 | $185 | $129 |
| Operating Income | -$155 | -$191 | -$132 | $72 |
| % Margin | -114.4% | -209.1% | -244.1% | 35.9% |
| Other Income/Exp. Net | $26 | $31 | $6 | -$0 |
| Pre-Tax Income | -$129 | -$160 | -$126 | $72 |
| Tax Expense | -$7 | -$13 | -$9 | $5 |
| Net Income | -$122 | -$147 | -$117 | $67 |
| % Margin | -90.5% | -160.9% | -217% | 33.4% |
| EPS | -2.27 | -2.76 | -2.47 | 1.51 |
| % Growth | 17.8% | -11.7% | -263.6% | – |
| EPS Diluted | -2.27 | -2.76 | -2.47 | 1.38 |
| Weighted Avg Shares Out | 54 | 53 | 47 | 44 |
| Weighted Avg Shares Out Dil | 54 | 53 | 47 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $26 | $31 | $6 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$154 | -$190 | -$131 | $73 |
| % Margin | -113.7% | -208.1% | -242.7% | 36.4% |